Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 66 Carcinoma, Renal Cell 38 Liver Neoplasms 20 Neoplasm Metastasis 17 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Breast Neoplasms 15 Melanoma 13 Thyroid Neoplasms 10 Leukemia, Myeloid, Acute 10 Sarcoma 9 Lung Neoplasms 8 Kidney Neoplasms 8 Prostatic Neoplasms 7 Ovarian Neoplasms 7 Urinary Bladder Neoplasms 6 Pancreatic Neoplasms 6 Glioblastoma 6 Brain Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Medullary 5 Thyroid Carcinoma, Anaplastic 4 Stomach Neoplasms 4 Rectal Neoplasms 4 Gliosarcoma 4 Gallbladder Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms, Male 4 Thyroid Diseases 3 Thyroid Cancer, Papillary 3

Interventions

Cyclophosphamide 34 Etoposide 25 Doxorubicin 20 Carboplatin 20 Vincristine 19 Isotretinoin 19 Topotecan 17 Temozolomide 17 Irinotecan 16 Filgrastim 16 Melphalan 15 Cisplatin 15 sargramostim 14 Radiotherapy 14 Granulocyte-Macrophage Colony-Stimulating Factor 13 3-Iodobenzylguanidine 12 dinutuximab 11 Peripheral Blood Stem Cell Transplantation 11 naxitamab 9 Thiotepa 9 Magnetic Resonance Spectroscopy 9 humanized 3F8 anti-GD2 monoclonal antibody 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 X-Rays 6 Specimen Handling 6 Phantoms, Imaging 6 Ifosfamide 6 Antilymphocyte Serum 6 fludarabine phosphate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroblastoma × Sorafenib × Clear all

NCT02559778 2026-04-28

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡